| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP, Chief Development Officer | Officer Level 14 | EVP, Chief Development Offc +2 more
1 company
Richard S Geary is EVP, Chief Development Officer at IONS. From January 2019 to November 2025, the filings on record show 0 open-market purchases and 22 sales. Richard S Geary's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $2.4M at current prices.
Historically, Richard S Geary's trades have earned a middling insider score of 66/100 across 19 rated trades. Over a 12-month horizon, 64.7% of those trades were profitable, with an average 12-month return of +1.2%.
The IONS filings lean toward selling, a net 342,724 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 17, 2024 | IONS Ionis Pharmaceuticals Inc | EVP, Chief Development Officer | Sale+OE | 7,338 | $50.42 | $369,959.95 | -7.9% | -19.0% | -37.1% | |
| Dec 21, 2023 | IONS Ionis Pharmaceuticals Inc | EVP, Chief Development Officer | Sale+OE10b5-1 | 10,612 | $49.50 | $525,323.99 | -12.7% | -12.9% | -27.4% | |
| Dec 14, 2023 | IONS Ionis Pharmaceuticals Inc | EVP, Chief Development Officer | Sale+OE10b5-1 | 10,613 | $49.58 | $526,236.45 | -12.7% | -13.4% | -26.5% | |
| Feb 6, 2023 | IONS Ionis Pharmaceuticals Inc | EVP, Chief Development Officer | Sell | 1,920 | $40.66 | $78,070.08 | -2.6% | -13.1% | +21.3% | |
| Jan 18, 2023 | IONS Ionis Pharmaceuticals Inc | EVP, Chief Development Officer | Sale+OE | 7,873 | $39.57 | $311,525.16 | -10.0% | -8.6% | +27.2% | |
| Jan 13, 2021 | IONS Ionis Pharmaceuticals Inc | EVP, Chief Development Offc | Sell | 141 | $59.50 | $8,389.50 | -0.5% | - | - | |
| Nov 25, 2020 | IONS Ionis Pharmaceuticals Inc | EVP, Development | Sale+OE | 11,920 | $50.05 | $596,596.00 | -28.1% | - | - | |
| Nov 24, 2020 | IONS Ionis Pharmaceuticals Inc | EVP, Development | Sale+OE | 13,080 | $50.24 | $657,152.40 | -30.1% | - | - | |
| Dec 4, 2019 | IONS Ionis Pharmaceuticals Inc | SVP, Development | Sale+OE | 10,000 | $65.00 | $650,000.00 | -31.7% | - | - | |
| Dec 2, 2019 | IONS Ionis Pharmaceuticals Inc | SVP, Development | Sale+OE | 5,000 | $65.06 | $325,287.00 | -18.8% | - | - |